Literature DB >> 2172356

Nocturnal oscillations in plasma renin activity during sleep in hypertensive patients: the influence of perindopril.

G Brandenberger1, J L Imbs, J P Libert, J Ehrhart, C Simon, J P Santoni, M Follenius.   

Abstract

In previous studies, we established a strong concordance between nocturnal oscillations in plasma renin activity (PRA) and REM-NREM sleep cycles. To determine whether this relation persists in the case of moderate essential hypertension and if it is influenced by antihypertensive therapies affecting renin release, six normal subjects and six hypertensive patients were studied. The normal subjects underwent one control night. The hypertensive patients were studied during a first night when a placebo was given. Four of them underwent a second night following a single dose of an angiotensin-converting enzyme (ACE) inhibitor, perindopril; and a third night, 45 days later, with the antihypertensive treatment. In addition, two of the patients underwent two night-studies, after a single and repeated doses of a beta-blocker, atenolol, to see whether preventing renin release modified the sleep structure. The relationship between the nocturnal PRA oscillations and the sleep stage patterns persisted in hypertensive patients receiving placebo. In patients who had low PRA levels, the increases associated with NREM sleep were small. However, the mean relative amplitude of the oscillations, expressed as a percentage of the nocturnal mean, was about 60%, which was similar to that in normotensive subjects. Active renin and PRA oscillations were closely coupled. ACE activity profiles displayed damped fluctuations and no systematic relationship with sleep stages.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2172356     DOI: 10.1007/BF03348625

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  27 in total

1.  Night-day differences in the ultradian rhythmicity of plasma renin activity.

Authors:  G Brandenberger; C Simon; M Follenius
Journal:  Life Sci       Date:  1987-06-15       Impact factor: 5.037

2.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

Review 3.  Angiotensin-converting enzyme inhibitors: past, present, and bright future.

Authors:  C R Edwards; P L Padfield
Journal:  Lancet       Date:  1985-01-05       Impact factor: 79.321

Review 4.  Clinical applications of angiotensin-converting enzyme inhibitors.

Authors:  R K Ferguson; P H Vlasses; H H Rotmensch
Journal:  Am J Med       Date:  1984-10       Impact factor: 4.965

5.  Selective activation of the converting enzyme inhibitor MK 421 and comparison of its active diacid form with captopril in different tissues of the rat.

Authors:  T Unger; B Schüll; W Rascher; R E Lang; D Ganten
Journal:  Biochem Pharmacol       Date:  1982-10-01       Impact factor: 5.858

6.  Dopaminergic regulation of circadian rhythms of blood pressure, renin and aldosterone in essential hypertension.

Authors:  J R Sowers; N Stern; M D Nyby; K A Jasberg
Journal:  Cardiovasc Res       Date:  1982-06       Impact factor: 10.787

7.  Quantitative analysis of spontaneous variations of plasma prolactin in normal man.

Authors:  E Van Cauter; M L'Hermite; G Copinschi; S Refetoff; D Desir; C Robyn
Journal:  Am J Physiol       Date:  1981-11

8.  Circadian rhythm of plasma renin activity in older normal and essential hypertensive men: relation with inactive renin, aldosterone, cortisol and REM sleep.

Authors:  N Stern; J R Sowers; D McGinty; E Beahm; M Littner; R Catania; P Eggena
Journal:  J Hypertens       Date:  1986-10       Impact factor: 4.844

9.  Rhythm characteristics of plasma renin, aldosterone and cortisol in five subtypes of mesor-hypertension.

Authors:  P Cugini; R Manconi; R Serdoz; A Mancini; T Meucci; D Scavo
Journal:  J Endocrinol Invest       Date:  1980 Apr-Jun       Impact factor: 4.256

10.  Effects of penbutolol and metoprolol on blood pressure, plasma catecholamines and renin activity in hypertensive patients.

Authors:  B G Hansson; J F Dymling; P Manhem; B Hökfelt
Journal:  Eur Heart J       Date:  1983-07       Impact factor: 29.983

View more
  2 in total

1.  5-HT2 receptors are partially involved in the relationship between renin release and delta relative power.

Authors:  G Brandenberger; R Luthringer; G Muller; C Gronfier; N Schaltenbrand; J P Macher; A Muzet; M Follenius
Journal:  J Endocrinol Invest       Date:  1996-09       Impact factor: 4.256

Review 2.  Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  A N Wadworth; D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.